Renal Function Monitoring

Introduction to Renal Function Assessment

• Renal function assessment can be affected by various factors, including muscle mass, liver disease, protein intake, and medication use, as noted by the National Kidney Foundation and the American Journal of Kidney Diseases 1, 2, 3, 4
• The accuracy of renal function assessment can be impacted by decreased muscle mass (sarcopenia), which is associated with elderly patients, malnutrition, cachexia, and advanced liver disease, according to the American Society of Nephrology and the American Journal of Kidney Diseases 1, 2, 5, 6

Estimating Glomerular Filtration Rate (GFR)

• The National Kidney Foundation recommends using the CKD-EPI equation as the most accurate method for estimating eGFR, with a strength of evidence of high quality 3, 2
• For patients with GFR <90 mL/min/1.73m², the MDRD study equation is an alternative accurate method for estimating eGFR, with a moderate level of evidence 2
• The American College of Transplantation recommends using CKD-EPI-CystC or combined CKD-EPI-Cr-CystC equations, which have superior performance (r²=0.78-0.83) compared to creatinine-based estimations (r²=0.76-0.77), to estimate GFR in patients with liver disease, with a high level of evidence 7
• Cystatin C-based GFR equations are recommended when available, especially in patients with advanced liver disease or sarcopenia, as they provide a more accurate estimate of renal function, with a moderate to high level of evidence 7

Interpreting Creatinine Levels

• Relying solely on serum creatinine can lead to inaccurate assessment of renal function, and eGFR should always be calculated, as recommended by the National Kidney Foundation 2
• Ignoring trends in creatinine levels can be misleading, as a stable elevated creatinine may be less concerning than a rising creatinine, with a low to moderate level of evidence 4
• Dynamic changes in creatinine should be monitored rather than absolute values, with an increase of ≥0.3 mg/dL within 48 hours or ≥50% from baseline indicating acute kidney injury (AKI), with a high level of evidence 5, 6, 8, 9, 10

Medication Dose Adjustment

• This table provides a general guideline for medication dose adjustment based on creatinine clearance, as recommended by the National Kidney Foundation and the American Journal of Kidney Diseases 2, 3

Referral and Management

• Referral to a nephrologist is warranted if eGFR <30 mL/min/1.73m², uncertainty about etiology of kidney dysfunction, worsening urinary albumin-to-creatinine ratio, rapidly decreasing eGFR, or persistent elevation of creatinine after discontinuation of creatine, as recommended by the American College of Cardiology and the National Kidney Foundation, with a high level of evidence 11, 12
• Nutritional intervention to address protein-energy malnutrition is essential, and exercise therapy to increase muscle mass can help improve serum creatinine levels, as noted by the Academy of Nutrition and Dietetics and the American College of Sports Medicine, with a moderate level of evidence 9, 13
• Assessing dietary protein intake is crucial, and the creatinine index can be used to estimate dietary skeletal muscle protein intake, as suggested by the American Journal of Kidney Diseases and the Academy of Nutrition and Dietetics, with a low to moderate level of evidence 13, 9

Special Considerations

• Clearance of exogenous markers (inulin, iohexol, iothalamate) and filtration and clearance of tagged radioisotopes are considered the gold standard for assessing renal function in liver disease, but have limitations such as being expensive and impractical for serial monitoring, as noted by the American Journal of Kidney Diseases, with a high level of evidence 7, 14, 15
• The American Journal of Kidney Diseases recommends using alternative methods to estimate GFR in patients with abnormally low creatinine, as serum creatinine can lead to artificially low values, resulting in overestimation of kidney function, with a moderate level of evidence 14, 15
• Creatine supplementation may add unnecessary nitrogenous load to compromised kidneys in CKD patients, and individuals with pre-existing kidney disease (eGFR <60 mL/min/1.73m²) should generally avoid creatine supplementation, while young, healthy individuals without risk factors can typically resume supplementation with proper monitoring, with a moderate level of evidence 11, 16, 12